Remove Pharma Remove Pharmaceutical manufacturing Remove Sales
article thumbnail

Big Pharma inventory management trends revealed

European Pharmaceutical Review

The inventory position of 28 major pharmaceutical manufacturers in 2022 has been revealed in an annual report. Analysis explored the impact of macro-trends on inventory management from corporate reports of Big Pharma companies including Merck, AstraZeneca and Pfizer. Sales grew by seven percent, totalling $994 billion in 2022.

article thumbnail

Pharma unite to secure renewable energy in key manufacturing markets

European Pharmaceutical Review

This step is important as these countries are key markets for pharmaceuticals manufacturing. Based on data on sales/value-based shares from various companies for APIs and Chemicals, India and China are estimated to account for up to half of materials for medicines, the Sustainable Markets Initiative (SMI) noted.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 119
article thumbnail

8 SEO Tips for Pharma Websites

PM360

It’s imperative that pharma businesses understand what their potential customers are searching for when they are typing into search fields. But pharma has had a tendency to shy away from search engine optimization (SEO) strategy; however, for those who do engage with SEO marketing, the rewards can be high.

Pharma 96
article thumbnail

How can the pharma industry address the gap in talent recruitment and development?

pharmaphorum

Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks. For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

AI IN PHARMACEUTICAL MARKETING: Optimizing Automation and Expertise

PM360

Challenges in Implementing AI So, does AI mark the end of laborious processes in pharma marketing? Pharma marketers rely on information technology (IT) expertiseeither internal or outsourcedto evolve back-end technology in lockstep with industry trends. The answer is yes and no.